Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ABCC9 | O60706 | ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2) | Disease related genesFDA approved drug targetsHuman disease related genesMetabolic proteinsPredicted membrane proteinsTransporters | 15 | Acute diabete complicationAngina pectorisMultiple sclerosisType 2 diabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 | ||
| ABCG2 | Q9UNQ0 | Broad substrate specificity ATP-binding cassette transporter ABCG2 (EC 7.6.2.2) (ATP-binding cassette sub-family G member 2) (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338) | Cancer-related genesCD markersEnzymesHuman disease related genesMetabolic proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 6 | Irritable bowel syndromeRheumatoid arthritis | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.50 | ||
| ABHD3 | Q8WU67 | Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3) | EnzymesPredicted intracellular proteinsPredicted membrane proteins | 1 | Metabolism mediation | 1 | 0.50 | |||
| ACHA2 | Q15822 | Neuronal acetylcholine receptor subunit alpha-2 (Nicotinic acetylcholine receptor subunit alpha-2) | 4 | Corneal diseaseDepressionGlaucomaNicotine use disorderTonus and reflex abnormality | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| ACKR3 | P25106 | Atypical chemokine receptor 3 (C-X-C chemokine receptor type 7) (CXC-R7) (CXCR-7) (Chemokine orphan receptor 1) (G-protein coupled receptor 159) (G-protein coupled receptor RDC1 homolog) (RDC-1) | Cancer-related genesDisease related genesG-protein coupled receptorsPotential drug targetsPredicted membrane proteins | 7 | AsthmaSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||
| ACTN1 | P12814 | Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1) | Disease related genesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| ADA | P00813 | Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase) | Disease related genesEnzymesFDA approved drug targetsHuman disease related genesMetabolic proteinsPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins | Adaptive immunity immunodeficiencyChronic painImmunodeficiencyMalignant haematopoietic neoplasmMature B-cell leukaemiaMultiple sclerosis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| ADA12 | O43184 | Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha) | Predicted membrane proteinsPredicted secreted proteinsTransporters | 1 | Receptor-signaling mediation | 1 | 0.50 | |||
| ADA23 | O75077 | Disintegrin and metalloproteinase domain-containing protein 23 (ADAM 23) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3) (MDC-3) | Predicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins | 1 | Other mediation | 1 | 0.50 | |||
| ADA33 | Q9BZ11 | Disintegrin and metalloproteinase domain-containing protein 33 (ADAM 33) (EC 3.4.24.-) | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Receptor-signaling mediation | 1 | 0.50 | |||
| ADCK5 | Q3MIX3 | Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-) | EnzymesPredicted membrane proteins | 1 | Other mediation | 1 | 0.50 | |||
| ADCY5 | O95622 | Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5) | Disease related genesEnzymesHuman disease related genesMetabolic proteinsPredicted membrane proteins | 12 | Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| ADCY7 | P51828 | Adenylate cyclase type 7 (EC 4.6.1.1) (ATP pyrophosphate-lyase 7) (Adenylate cyclase type VII) (Adenylyl cyclase 7) (Cyclic di-AMP synthase ADCY7) (EC 2.7.7.85) | EnzymesMetabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 12 | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| ADCY8 | P40145 | Adenylate cyclase type 8 (EC 4.6.1.1) (ATP pyrophosphate-lyase 8) (Adenylate cyclase type VIII) (Adenylyl cyclase 8) (AC8) (Ca(2+)/calmodulin-activated adenylyl cyclase) | EnzymesMetabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 12 | Clinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| ADRB2 | P07550 | Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor) | 7 | AsthmaBladder disorderBreast cancerCachexiaCardiovascular diseaseChronic obstructive pulmonary diseaseConduction disorderDermal/subcutaneous connective tissue atrophy/degenerationEjaculatory dysfunctionHypertensionMelanomaObesityPreterm labour/deliverySkin and skin-structure infectionSleep-related breathing disorderStomach cancerSupraventricular tachyarrhythmia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 1 | 0.50 | |||
| AGRA2 | Q96PE1 | Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124) (Tumor endothelial marker 5) | G-protein coupled receptorsPredicted intracellular proteinsPredicted membrane proteins | 7 | Receptor-signaling mediation | 1 | 0.50 | |||
| AGRB2 | O60241 | Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2) | 7 | Receptor-signaling mediation | 1 | 0.50 | ||||
| AGRE5 | P48960 | Adhesion G protein-coupled receptor E5 (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: Adhesion G protein-coupled receptor E5 subunit alpha; Adhesion G protein-coupled receptor E5 subunit beta] | CD markersG-protein coupled receptorsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteinsTransporters | 7 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | |||
| AGRG2 | Q8IZP9 | Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Human epididymis-specific protein 6) (He6) [Cleaved into: Adhesion G-protein coupled receptor G2, N-terminal fragment (ADGRG2 N-terminal fragment); Adhesion G-protein coupled receptor G2, C-terminal fragment (ADGRG2 C-terminal fragment)] | Disease related genesG-protein coupled receptorsHuman disease related genesPlasma proteinsPotential drug targetsPredicted membrane proteinsTransporters | 7 | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.50 | |||
| AGRG7 | Q96K78 | Adhesion G-protein coupled receptor G7 (G-protein coupled receptor 128) | 7 | Receptor-signaling mediation | 1 | 0.50 | ||||
| AJM1 | C9J069 | Apical junction component 1 homolog | Predicted intracellular proteins | Fusion and delivery mediation | 1 | 0.50 | ||||
| AKA12 | Q02952 | A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 1 | 0.50 | ||||
| ALK | Q9UM73 | ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) | Cancer-related genesCD markersDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Adrenal cancerBreast cancerColorectal cancerDiffuse large B-cell lymphomaLung cancerLymphomaMature T-cell lymphomaMetastatic tumourNon-small-cell lung cancerSolid tumour/cancer | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.50 | ||
| AMGO2 | Q86SJ2 | Amphoterin-induced protein 2 (AMIGO-2) (Alivin-1) (Differentially expressed in gastric adenocarcinomas) (DEGA) | Predicted membrane proteins | 1 | Adhesion and uptake mediationReceptor-signaling mediation | 1 | 0.50 | |||
| AMPN | P15144 | Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13) | CD markersEnzymesMetabolic proteinsPlasma proteinsPredicted membrane proteins | 1 | Psoriasis | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.50 |